CM

Catherine Mohr

Aroa Biosurgery Limited | Non-Executive Director
Dr Mohr has experience across engineering, healthcare, alternative energy, aerospace and entrepreneurship. Her background includes medical technology product research and development, regulatory approvals, product commercialisation and surgical technology. She has held senior strategy and medical research roles and co-founded VeriSure, where she developed the LapCap, a laparoscopic surgery product. She has experience in medical technology innovation and the development of healthcare products.

Company and Role

Company
Title
Tenure
Since
ARX
Aroa Biosurgery Limited
  • Non-Executive Director
3yrs, 8mthNov 2022

Holding

Company
Last Notice
Direct Shares
Indirect Shares
Options
Convertibles
ARX
Aroa Biosurgery Limited
31/03/26N/A436,364210,686N/A

Transactions

Company
Date
Type
Amount
Price
Value
Notes
ARX
Aroa Biosurgery Limited
30/09/24
Buy
436,364$0.375$163,453On-market trade
ARX
Aroa Biosurgery Limited
11/08/23
Issued
210,686$0.880$185,403Issue of options